Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Proposal for a real life distribution of Italian health care resources for respiratory allergic diseases

From: Appropriateness in allergic respiratory diseases health care in Italy: definitions and organizational aspects

  I level II level III level Availability, for the National Health Care Service Availability, for habitants (×1000)
Consultant for allergy    TS and HS I level 80–150
Skin prick test (inhalants, foods, latex)    TS and HS I level 80–150
Spirometry F/V curve    TS and HS I level 80–150
Reversibility test    TS and HS I level 80–150
Total IgE    HS I level 150–300
Specific IgE, panel for inhalants    HS I level 150–300
Specific IgE, panel for foods    HS I level 150–300
Component resolved diagnosis    HS I–II level 600–1200
Spirometry, lung volumesa    HS I level 150–300
Spirometry, DLCOa    HS I level 150–300
Methacholine–challengea    HS I level 150–300
Mannitol challengea    HS I–II level 300–600
Exhaled nitric oxide (FeNO) measurement    HS I level 150–300
Exercise challengea    HS I level 150–300
CPETa    HS I–II level 300–600
Severe asthma centerb    HS I–II level 300–600
HymenopteraVIT centerb    HS I–II level 300–600
Pharmacoallergy centerb    HS II level 600–1200
  1. TS territorial services, HS hospital setting, CPET cardiopulmonary exercise testing, VIT venom immunotherapy
  2. aResources to be present in clinical respiratory physiology unit
  3. bBoard certified centers